InnovAge (OTCMKTS:INNV) Trading Down 4.6% – What’s Next?

InnovAge Holding Corp. (OTCMKTS:INNVGet Free Report)’s stock price traded down 4.6% during mid-day trading on Thursday . The stock traded as low as $4.55 and last traded at $4.58. 28,264 shares traded hands during trading, a decline of 26% from the average session volume of 38,268 shares. The stock had previously closed at $4.80.

InnovAge Stock Performance

The company has a 50-day moving average price of $5.42 and a two-hundred day moving average price of $5.53. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $620.38 million, a PE ratio of -38.17 and a beta of 0.31.

InnovAge (OTCMKTS:INNVGet Free Report) last issued its quarterly earnings data on Tuesday, September 10th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.02) by $0.01. InnovAge had a negative return on equity of 13.04% and a negative net margin of 6.17%. The company had revenue of $199.40 million during the quarter, compared to analyst estimates of $190.19 million. Analysts predict that InnovAge Holding Corp. will post -0.25 EPS for the current fiscal year.

About InnovAge

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Featured Articles

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.